FOXO Technologies Inc. announced plans for a new subscription-based, direct-to-consumer product offering that will provide personalized health and wellness recommendations, by combining: (i) FOXO's machine learning models to analyze epigenetic biomarkers; (ii) the Company's expertise and algorithms correlating epigenetic analysis with health outcomes; and (iii) published, peer-reviewed, clinical data and other verified, third-party health resources. In connection with the new offering, the Company also announced it has formed a collaboration with KR8.ai Inc. ("KR8") and secured an exclusive license to KR8's AI-based software to support the development and commercial launch of the new health and wellness offering.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.291 USD | -2.22% | -2.71% | -8.98% |
04-28 | FOXO Technologies Inc. announced that it has received $0.11 million in funding from LGH Investments, LLC | CI |
04-24 | Sector Update: Tech Stocks Higher Premarket Wednesday | MT |
1st Jan change | Capi. | |
---|---|---|
-8.98% | 3.01M | |
-13.15% | 192B | |
+0.71% | 167B | |
+6.44% | 156B | |
+8.05% | 103B | |
+36.55% | 84.35B | |
+11.41% | 82.24B | |
-7.05% | 71.76B | |
-18.30% | 55.03B | |
-8.47% | 43.53B |
- Stock Market
- Equities
- FOXO Stock
- News FOXO Technologies Inc.
- FOXO Technologies Inc. Unveils Plans for New Direct-To Consumer Offering Combining the Company's Epigenetic Data with the Power of Ai